PARP inhibitors for ovarian cancer

Promising Efficacy in Colorectal and Ovarian Cancer: Insights from Dr. Jenny Liu | OncoDailyПодробнее

PARP Inhibitors in Ovarian Cancer Treatment: Understanding Side EffectsПодробнее

The ABCs of ADCs: Ovarian Cancer and Antibody Drug ConjugatesПодробнее

Chemotherapy: PARP-inhibitors, Bevacizumab, and Ovarian CytotoxicsПодробнее

Ovarian Cancer: Understanding Risk Factors, Diagnosis & TreatmentПодробнее

My Journey with Ovarian Cancer, #10, PARP InhibitorsПодробнее

What Clinical Trials Are Recruiting for Recurrent Ovarian Cancer?Подробнее

Advancing Therapeutic Paradigms for Ovarian Cancer in The Era of PARP Inhibitors: A Guide for The...Подробнее

Clinical Advances in Ovarian Cancer: Exploring the Expanding Role of PARP Inhibitors in the Treat...Подробнее

Ovarian Cancer & PARP Inhibitors with Dr. B.S. Ankit Nehra | Oncology Perspective 2024Подробнее

What are PARP Inhibitors?Подробнее

Fight Ovarian Cancer: Hope & Heal Experts Discuss on World Ovarian Cancer Day (English)Подробнее

Evaluating future use of PARP inhibitors in neoadjuvant therapy for ovarian cancerПодробнее

PARP Inhibitor Maintenance in Newly Diagnosed Ovarian Cancer: Key Questions, Answers, and Insights Подробнее

PARP Inhibitors in Prostate Cancer Treatment - Program: Patient Education Ambassadors 2023-24Подробнее

Integrating New Research Information into Current Clinical Care — Ovarian CancerПодробнее

Precision Medicine in Oncology: Ep.9 DEBATE - Is PARP inhibitor maintenance therapy in first-line...Подробнее

Let’s Talk Ovarian Cancer: Management of PARP Inhibitor Maintenance Treatment in PatientsПодробнее

Identifying optimal patient subgroups in ovarian cancer for neoadjuvant PARP inhibitor therapyПодробнее

The Pulse on Progress - Insights into Ovarian CancerПодробнее